Boston Scientific small vessel stent
This article was originally published in The Gray Sheet
Executive Summary
FDA approves PMA supplement for Boston Scientific's Taxus Liberte Atom paclitaxel-eluting coronary stent May 21, paving the way for a June U.S. launch. The "highly deliverable," next-generation device joins the Taxus Express Atom as the only drug-eluting stents approved for vessels as small as 2.25 mm in diameter, the company says